Literature DB >> 11953602

Long-term followup of proximal femoral allografts.

Edward J Fox1, Mohammad Anwar Hau, Mark C Gebhardt, Francis J Hornicek, William W Tomford, Henry J Mankin.   

Abstract

Between 1972 and 1999, the orthopaedic service at the authors' institution treated 137 patients with proximal femoral bone lesions by resection and reconstruction with frozen allografts from cadavers. The data were entered into a computer program allowing a comprehensive analysis. Thirty-eight patients had proximal femoral osteoarticular allografts, 69 had allograft-endoprosthesis composites, 22 had intercalary allografts, and eight had an allograft arthrodesis. There were 74 complications in 54 of the 137 patients with allografts, which included 26 allograft fractures (19%), 15 infections (11%), and 20 nonunions (15%). The overall success rate for the patients with these procedures was 103 of 137 (75%) at a mean followup of 7.9 years +/- 5.6 years. If the eight patients with tumor recurrences (surgical failures rather than allograft failures) are not included, the success rate is 103 of 129 (80%). Eighty-three of these patients (55%) without any allograft complications who have been treated and followed up for at least 2 years had a 92% success rate. It is concluded that although allograft reconstruction after resection of the proximal femur for patients with aggressive or malignant tumors has a high complication rate, approximately 80% of the patients have a successful outcome.

Entities:  

Mesh:

Year:  2002        PMID: 11953602     DOI: 10.1097/00003086-200204000-00015

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  22 in total

1.  Surgical revascularization induces angiogenesis in orthotopic bone allograft.

Authors:  Wouter F Willems; Thomas Kremer; Patricia Friedrich; Allen T Bishop
Journal:  Clin Orthop Relat Res       Date:  2012-09       Impact factor: 4.176

Review 2.  [Extracorporeal irradiation : Reimplantation of bone segments in the treatment of malignant bone tumours].

Authors:  A H Krieg
Journal:  Orthopade       Date:  2017-08       Impact factor: 1.087

3.  Revision of the deficient proximal femur with a proximal femoral allograft.

Authors:  Oleg Safir; Catherine F Kellett; Michael Flint; David Backstein; Allan E Gross
Journal:  Clin Orthop Relat Res       Date:  2008-10-30       Impact factor: 4.176

4.  [Proximal and total femur replacement].

Authors:  P H Pennekamp; D C Wirtz; H R Dürr
Journal:  Oper Orthop Traumatol       Date:  2012-07       Impact factor: 1.154

Review 5.  A perspective: engineering periosteum for structural bone graft healing.

Authors:  Xinping Zhang; Hani A Awad; Regis J O'Keefe; Robert E Guldberg; Edward M Schwarz
Journal:  Clin Orthop Relat Res       Date:  2008-05-29       Impact factor: 4.176

6.  Curettage and cryosurgery for low-grade cartilage tumors is associated with low recurrence and high function.

Authors:  David G Mohler; Richard Chiu; David A McCall; Raffi S Avedian
Journal:  Clin Orthop Relat Res       Date:  2010-06-24       Impact factor: 4.176

7.  Custom-made intercalary endoprosthetic reconstruction for a parosteal osteosarcoma of the femoral diaphysis: A case report.

Authors:  Shi-Chang Zhao; Chang-Qing Zhang; Chun-Lin Zhang
Journal:  Oncol Lett       Date:  2015-08-24       Impact factor: 2.967

8.  Long-term results for limb salvage with osteoarticular allograft reconstruction.

Authors:  Christian M Ogilvie; Eileen A Crawford; Harish S Hosalkar; Joseph J King; Richard D Lackman
Journal:  Clin Orthop Relat Res       Date:  2009-02-13       Impact factor: 4.176

9.  Results of 32 allograft-prosthesis composite reconstructions of the proximal femur.

Authors:  David J Biau; Frédérique Larousserie; Fabrice Thévenin; Sophie Piperno-Neumann; Philippe Anract
Journal:  Clin Orthop Relat Res       Date:  2009-10-23       Impact factor: 4.176

10.  Bisphosphonate delivery to tubular bone allografts.

Authors:  Gene R DiResta; Mark W Manoso; Anwar Naqvi; Pat Zanzonico; Peter Smith-Jones; Wakenda Tyler; Carol Morris; John H Healey
Journal:  Clin Orthop Relat Res       Date:  2008-04-26       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.